How to appeal a Dialysis (MCP) Billing & ESA Denials denial
Nephrology dialysis denials split two ways: the monthly capitation (MCP) code denied on the visit-count tier or overlapping providers, and the ESA anemia-drug J-code denied on the hemoglobin/hematocrit coverage thresholds.
Common code: CPT 90957-90962 (monthly capitation MCP), 90935/90937 (inpatient HD) + J0885/J0888 (ESA: epoetin/darbepoetin)Why it gets denied
- The MCP code (90957-90962) billed didn't match the number of documented face-to-face visits that month
- Two providers billed overlapping MCP for the same patient and month
- The ESA was denied because the hemoglobin exceeded the coverage threshold or the level wasn't documented
- The J-code units didn't reconcile to the administered dose
What overturns it
- Map the MCP code to the exact number of documented monthly visits and the patient's age
- Resolve overlapping-provider MCP by documenting who managed the month
- Submit the hemoglobin/hematocrit values that meet the ESA coverage policy
- Reconcile the ESA units to the dose administered
Worth appealing? The monthly MCP is recurring per-patient revenue and ESA drugs are buy-and-bill, so denials repeat every month across the dialysis panel. They're recoverable when the visit documentation and lab values are mapped to the coverage tiers.
Common questions
How do I appeal a Dialysis (MCP) Billing & ESA Denials denial?
Nephrology dialysis denials split two ways: the monthly capitation (MCP) code denied on the visit-count tier or overlapping providers, and the ESA anemia-drug J-code denied on the hemoglobin/hematocrit coverage thresholds. To overturn it: map the MCP code to the exact number of documented monthly visits and the patient's age; resolve overlapping-provider MCP by documenting who managed the month; submit the hemoglobin/hematocrit values that meet the ESA coverage policy; reconcile the ESA units to the dose administered.
Why do Dialysis (MCP) Billing & ESA Denials claims get denied?
The MCP code (90957-90962) billed didn't match the number of documented face-to-face visits that month; Two providers billed overlapping MCP for the same patient and month; The ESA was denied because the hemoglobin exceeded the coverage threshold or the level wasn't documented; The J-code units didn't reconcile to the administered dose.
Is a Dialysis (MCP) Billing & ESA Denials denial worth appealing?
The monthly MCP is recurring per-patient revenue and ESA drugs are buy-and-bill, so denials repeat every month across the dialysis panel. They're recoverable when the visit documentation and lab values are mapped to the coverage tiers. You pay 25% only on what's recovered, so there's no cost to working the winnable ones.
See how many Dialysis (MCP) Billing & ESA Denials denials you wrote off.
A free assessment shows your real recoverable number. No risk, paid only on what we recover.